About Conference

The 29^th Conference on Neuropharmacology and Neurochemistry at the prestigious on April 28-29, 2025 in Dubai, UAE. The event brought together a distinguished gathering of keynote speakers, experts, and participants from leading institutions and organizations worldwide. The central theme, "Neurology in the Digital Age: Harnessing Technology for Advancements in Brain Health," set the stage for two days of insightful discussions and groundbreaking presentations.

The scientific program was rich and diverse, featuring keynote addresses and specialty sessions that covered an extensive range of topics, including neuropharmacology, pediatric neurology, clinical neurology, and neurosurgery. A highlight of the conference was the keynote address by Abdul hafiz Hakim from Ain Shams University, who delivered an impactful presentation on hypoparathyroidism in Aicardi-Goutières syndrome.

Throughout the event, attendees engaged in vibrant discussions and knowledge exchange, particularly during sessions that showcased the latest developments in neurology and related fields. Cutting-edge research and clinical case studies were brought to life through poster presentations and e-poster sessions, providing an interactive platform for sharing ideas and fostering collaborations.

The conference received overwhelmingly positive feedback, with many participants already looking forward to the next edition. The success of the event is a testament to the dedication and hard work of the speakers, attendees, and sponsors, for which the organizing committee extends its deepest gratitude.

Session and Tracks

Track 1: Neuropharmacology and Neurochemistry
Track 2: Molecular and cellular neurochemistry
Track 3: Neurological Disorders and Stroke
Track 4: Clinical Neurophysiology and Stroke
Track 5: Alzheimer’s and Parkinson’s Diseases
Track 6: Neuroimmunology and Neurological Infections
Track 7: Brain Injury and Behavioural Neuroscience
Track 8: Neuropharmacology and genetic aspects of CNS function
Track 9: Cognitive Neuroscience and Psychology
Track 10: CNS and Brain Disorders
Track 11: Neuroscience and Artificial Intelligence
Track 12: Neuroinformatics and Computational Neuroscience
Track 13: Human Brain Mapping
Track 14: Brain Stimulation and Imaging
Track 15: Neurogenesis
Track 16: Neurotherapeutics and Case Studies
Track 17: Brain Structure and Function
Track 18: Pre- and post-synaptic function
Track 19: Synapse formation and neurotransmitter receptors
Track 20: Synaptic Function and Dysfunction in Brain Diseases
Track 21: Synaptic plasticity and memory
Track 22: Brain Pathology and Oncology Research
Track 23: Stem Cells Role in Neuro-Biological Treatment
Track 24: Neurobiology and Behaviours
Track 25: Neurorehabilitation and Neural Repair

Market Analysis

The Global Neurology market is expected to increase at a compound annual growth rate (CAGR) of 3.5 percent from $33.3 billion in 2019 to $39.4 billion in 2024. A recent WHO survey suggested that various neurological disorders collectively accounts for more than 12% of global deaths on average, and it is predicted that the number of death occurring due to neurological diseases will rise from 95 million in 2015 to approximately 103 million in 2030. In 2010, the global cost associated with neurological diseases was estimated to be US$ 2.5 trillion, and it is expected to be over US$ 6 trillion in 2030. High-impacting elements such as ongoing neuro mapping research, government initiatives based on neuroscience, and algorithms used in the neuroscience sectors are driving the market growth.

The Neurology Device market is growing rapidly with a CAGR of 4% from USD 33 billion in 2019 to USD 39 billion by 2023. The neurology device market can be divided into two segments. The neurology market is segmented according to device types which include neurosurgical devices, CSF devices, neurostimulation devices, and cerebrospinal fluid devices accounts for the maximum share of the market. According to the geography segment, it is divided into the following regions: North America, Eastern Europe, Middle East, South America, Asia-Pacific, and Africa. Among these Asia-Pacific is the fastest-growing region and North America is the largest market for Neurological devices.(Read More)

Young Researchers Form

The Pharma Conference Committee is dedicated to honouring and recognizing the achievements of exceptional young researchers, scientists, young investigators, post-graduate students, post-doctoral fellows, trainees, and junior faculty members for their significant contributions in advancing the field of Neuropharmaceutics. These prestigious awards are designed to acknowledge the outstanding work done by early-career professionals in the field of pharmacology, neuroscience, and neuropharmacology, in alignment with the theme of Neuropharmaceutics 2025.

The Young Scientist Awards serve as a platform for these talented individuals to gain recognition for their pioneering research, providing them with a valuable professional development opportunity. By participating in this event, awardees will have the chance to meet with experts and peers from around the world, exchanging insights, knowledge, and experiences on the latest trends, advancements, and challenges in the pharma and neuroscience sectors. This initiative not only aims to celebrate academic excellence but also supports the professional growth of emerging scientists by fostering connections with established leaders in the field.

The Young Researcher Awards at Neuropharmaceutics 2025 will specifically recognize outstanding Masters, Ph.D., and Post-Doctoral thesis work that significantly contributes to the scientific community. The Young Researcher Forum will provide a unique opportunity for the selected candidates to present their research findings to an international audience of academics, industry professionals, and thought leaders in neuropharmacology. A key element of this forum is the highly competitive nature of the selection process, with only 25 presentations being accepted at the Neuropharmaceutics 2025 Young Researcher Forum. These select presentations will showcase the ground-breaking research that has the potential to shape the future of neuropharmacology and neuroscience, reflecting the high standards of academic excellence the conference seeks to promote.

Important Guidlines

Abstract submission:  Dec 28, 2024

First phase registration: Feb 28, 2025

Final registration: April 28 2025

Book your slot: http://neuropharmaceutics.conferenceseries.com/registration.php

Group registration (Minimum 5 members) can avail 20% waivers from the registration fee.

Abstract submission guidelines for Neuropharmacology conferences:

Kindly go through these guidelines before submitting you’re abstract:

• If you choose to participate in this conference, you need to submit an abstract
• The abstract should carry the summary of a research
• Abstract should be submitted either through e-mail or using the link given below
• Abstracts should be based on any areas as listed in this website as sessions/tracks

Note: The review process for the submitted abstract will take 24 Hours.

Submitting abstract will be published in conference proceedings in the conference supporting journal 

For Abstract Submission Gothrough: Submit Now!
 

Email: Program Manager at  neurologicaldisorder@meconferences.org or WhatsApp +447915641825 with details of the participant.

Thanks and Regards,
Program Manager
Paediatrics Organizing Committee
WhatsApp: +447915641825